In the latter, RAS mutations are mutually exclusive with somatic RET mutations and rare in patients affected by multiple endocrine neoplasia type 2 (MEN2) due to germline RET mutation. The gene discussed is RET; the disease is multiple endocrine neoplasia type 2.